Synthetic Biologics to Participate in Fireside Chat at RBC Capital Markets' Global Healthcare Conference Feb 16, 2016 04:01PM
RBC Believes it Makes Sense for Synthetic Biologics (SYN) to Stop Copaxone + Trimesta Arm; 'Outperform' Rating Affirmed Feb 2, 2016 12:32PM
Synthetic Biologics (SYN) Seen as Undervalued at RBC Capital Jan 20, 2016 07:13AM
Streetinsider.com's Hot Lunchtime Reads 12/1: (AMZN) (AGO) (SYN) (BLUE) Dec 1, 2015 12:23PM
RBC Capital Remains Positive on Synthetic Biologics (SYN) Following SYN-004 Phase 2a Update Dec 1, 2015 11:07AM


Oct 13, 2015 10:26AM Notable Analyst Rating Changes 10/13: (TOL) (MPEL) (POT) Upgraded; (ACI) (SKYW) (PHM) Downgraded
Oct 13, 2015 07:27AM RBC Capital Starts Synthetic Biologics (SYN) at Outperform, PT $8
Jul 21, 2015 09:24AM Synthetic Biologics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option
Jul 16, 2015 08:56AM Synthetic Biologics (SYN) Prices 13.3M Common Stock Offering at $3/Share
Jul 16, 2015 08:55AM Synthetic Biologics Announces Pricing of $40.0 Million Public Offering
Jul 15, 2015 04:08PM Synthetic Biologics (SYN) Annoucnes Common Stock Offering
Jul 15, 2015 04:05PM Synthetic Biologics Announces Public Offering of Common Stock
Jun 1, 2015 10:42AM Notable Analyst Rating Changes 6/1: (C) (KO) (ABEV) Upgraded; (CLD) (JNPR) (MRTX) Downgraded
Dec 12, 2013 09:29AM Pre-Open Stock Movers 12/12: (BAXS) (UNS) (ARCW) Higher; (IMUC) (LULU) (CIEN) Lower (more...)